Bill

Bill > A1909


NJ A1909

NJ A1909
Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.


summary

Introduced
01/09/2024
In Committee
01/09/2024
Crossed Over
Passed
Dead
01/12/2026

Introduced Session

2024-2025 Regular Session

Bill Summary

This bill requires that carriers that provide coverage for prescription drugs pursuant to the terms of a health benefits plan offered by the carrier are prohibited from requiring a covered person to pay an amount exceeding $100 for a 30 day supply of insulin; or an amount exceeding $100 for a package of two epinephrine auto-injector devices. In addition, the bill requires the Division of Consumer Affairs in the Department of Law and Public Safety to investigate the pricing of prescription insulin drugs that are available to New Jersey consumers to determine whether additional consumer protections in the pricing of prescription insulin drugs are needed. The division is required to issue and make available to the public a report detailing its findings and present the report to the Governor, the Commissioner of Banking and Insurance, and the Legislature.

AI Summary

This bill requires that carriers providing health insurance coverage in New Jersey cannot require covered persons to pay more than $100 for a 30-day supply of insulin or a package of two epinephrine auto-injector devices. Additionally, the bill directs the Division of Consumer Affairs to investigate the pricing of prescription insulin drugs available to New Jersey consumers and issue a report with recommendations on how to control and prevent the overpricing of these drugs and prevent deceptive sales practices related to their sale and pricing.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced, Referred to Assembly Financial Institutions and Insurance Committee (on 01/09/2024)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...